1. Anonymous. [Evaluation of the technology employed in health care]. Rev Panam Salud Publica. 1997;2:363–372.
2. Banta, D. A review of health technology assessment methods in the field of pharmaceuticals. Poland: TNO Prevention and Health. Ministry of Health, Office for Foreign Aid Programs in Health Care, Poland. This report is part of a project that was financed through World Bank Loan 3466-POL; 2002.
3. Banta, HD, Gelband, H, Jonsson, E, Battista, RN. Special issue: Health care technology and its assessment in eight countries: Australia, Canada, France, Germany, Netherlands, Sweden, United Kingdom, United States. Health Policy. 1994; 30:1–421.
4. Barbieri, M, Drummond, M, Willke, R, et al. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: Lessons for inferring generalizability. Value Health. 2005;8:10–23.
5. Battista, RN. Expanding the scientific basis of health technology assessment: A research agenda for the next decade. Int J Technol Assess Health Care. 2006;22:275–280; discussion 280–272.
6. Brehaut, JD, Juzwishin, D. Bridging the gap: The use of research evidence in policy development. Alberta, Canada: Alberta Heritage Foundation of Medical Research (AHFMR); 2005:1–29.
7. Bronner, D, Federal Joint Committee (G-BA). Assessment of benefit Implementation of medical innovations in Germany. (Oral presentation). College voor zorgverzekeringen (CVZ) and Gemeinsamer Bundesausschuss (G-BA), January 26. Amsterdam 2007.
8. Bundesgesetzblatt. Art. §35b Benefit and cost assessment of drugs. [Social Code Book V. Statutory Health Insurance. Based on Art. 1 Social Security Code V on Social Health of 20th December 1988, BGBl. I S. 2477. Last revision based on Art. 5 G of 2007 April 20]. Bundesgesetzblatt.
9. Bundesgesetzblatt. Art. §139a The Institute for Quality and Efficiency in Health Care. [Social Code Book V. Statutory Health Insurance. Based on Art. 1 Social Security Code V on Social Health of 20th December 1988, BGBl. I S. 2477. Last revision based on Art. 5 G of 2007 April 20]. Bundesgesetzblatt.
10. Bundesgesetzblatt. Art. §139b Conduct of tasks. [Social Code Book V. Statutory Health Insurance. Based on Art. 1 Social Security Code V on Social Health of 20th December 1988, BGBl. I S. 2477. Last revision based on Art. 5 G of 2007 April 20]. Bundesgesetzblatt.
11. Bundesgesetzblatt. Art. §139c Funding. [Social Code Book V. Statutory Health Insurance. Based on Art. 1 Social Security Code V on Social Health of 20th December 1988, BGBl. I S. 2477. Last revision based on Art. 5 G of 2007 April 20]. Bundesgesetzblatt.
12. Bundesgesetzblatt. Statutory Health Insurance [SHI] - Act to Promote Competition (GKV-Wettbewerbsstaerkungsgesetz – GKV-WSG) of March 26 2007. Bundesgesetzblatt Part I No. 11 administered at Bonn March 30, 2007. pp. 378–473.
13. Chinitz, D. Health technology assessment in four countries: Response from political science. Int J Technol Assess Health Care. 2004;20:55–60.
14. Cox, P. Financing sustainable health care in Europe: New approaches for new outcomes. Conclusions from a collaborative investigation into contentious areas of healthcare. Helsinki: www.sustainhealthcare.org 2007. pp 1–192.
15. Cranovsky, R, Matillon, Y, Banta, D. EUR-ASSESS project subgroup report on coverage. Int J Technol Assess Health Care. 1997;13:287–332.
16. Degos, L. Benefit of health technologies: Where do we come from, where are we now, where do we go? (Oral presentation). IQWiG Herbstsymposium: Wissen als Entscheidungsgrundlage für Patienten und Ärzte (Nov 23). Der finanzielle Wert von Krankheit und Gesundheit (Nov 24). Cologne, Germany: November 24, 2007.
17. Dickson, M, Hurst, J, Jacobzone, S. Survey of pharmacoeconomic assessment activity in eleven countries. Paris: Directorate for Employment, Labour and Social Affairs, Employment, Labour and Social Affairs Committee; 2003:1–44.
18. Dowie, J. Research implications of science-informed, value-based decision making. Int J Occup Med Environ Health. 2004;17:83–90.
19. Draborg, E, Andersen, CK. Recommendations in health technology assessments worldwide. Int J Technol Assess Health Care. 2006;22:155–160.
20. Draborg, E, Andersen, CK. What influences the choice of assessment methods in health technology assessments? Statistical analysis of international health technology assessments from 1989 to 2002. Int J Technol Assess Health Care. 2006;22:19–25.
21. Draborg, E, Gyrd-Hansen, D. Time-trends in health technology assessments: An analysis of developments in composition of international health technology assessments from 1989 to 2002. Int J Technol Assess Health Care. 2005;21:492–498.
22. Draborg, E, Gyrd-Hansen, D, Poulsen, PB, Horder, M. International comparison of the definition and the practical application of health technology assessment. Int J Technol Assess Health Care. 2005;21:89–95.
23. Drummond, M, Manca, A, Sculpher, M. Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005;21:165–171.
24. Drummond, M, Schwartz, JS, Jonsson, B, et al. The international working group for HTA advancement. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244–258.
25. Drummond, M, Schwartz, JS, Jonsson, B, et al. The International Working Group for HTA Advancement. Key principles for the improved conduct of health technology assessments for resource allocation decisions: Authors reply. Int J Technol Assess Health Care. 2008;24:367–368.
26. Easton, D. The political system: An inquiry into the stale of political science. New York: Knopf; 1953.
27. EUnetHTA. European network for Health Technology Assessment (Oral presentation). Fourth Annual Meeting of Health Technology Assessment International (HTAi) June 17-20. Barcelona, Spain 2007.
28. European Commission. The Swedish Council on Technology Assessment in Health Care (SBU). The ECHTA/ECAHI Project. 1999:1–552.
30. Ferguson, JH, Dubinsky, M, Kirsch, PJ. Court-ordered reimbursement for unproven medical technology. Circumventing technology assessment. [see comment]. JAMA. 1993;269:2116–2121.
31. Francke, R, Hart, D. [HTA in the decision-making processes of health care institutions. Current state and relevant questions of regulatory health law]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2006;49:241–250.
32. Freeman, JM. Beware: The misuse of technology and the law of unintended consequences. Neurotherapeutics. 2007;4:549–554.
33. Gagnon, MP, Sanchez, E, Pons, JM. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia. Int J Technol Assess Health Care. 2006;22:169–176.
34. Garcia-Altes, A, Ondategui-Parra, S, Neumann, PJ. Cross-national comparison of technology assessment processes. Int J Technol Assess Health Care. 2004;20:300–310.
35. Gerhardus, A, Dintsios, CM. [Der Einfluss von HTA-Berichten auf die gesundheitspolitische Entscheidungsfindung - Eine systematische Übersichtsarbeit] The impact of HTA reports on decision-making processes in the health sector in Germany. Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health. Köln: DAHTA@DIMDI; 2005:1–111.
36. Gibis, B, Rheinberger, P. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients]. Z Arztl Fortbild Qualitatssich. 2002;96:82–90.
37. Goodman, CS. HTA 101: Introduction to health technology assessment [Update of 1998, webpublished on NLM]. Virginia: The Lewin Group; 2004:1-155.
38. Granados, A, Jonsson, E, Banta, HD, et al. EUR-ASSESS project subgroup report on dissemination and impact. Int J Technol Assess Health Care. 1997;13:220–286.
39. Hailey, D. Elements of effectiveness for health technology assessment programs. Alberta, Canada: Alberta Heritage Foundation of Medical Research; 2003:1–41.
40. Hansson, SO. Decision theory. Brief introduction. Stockholm, Sweden: Department of Philosophy and the History of Technology, Royal Institute of Technology (KTH); 1994:1–94.
41. Haute Autorité de Santé. Code de la sécurité sociale. Version à venir au 1 juin 2008. Chapitre 1 bis. Paris: Haute Autorité de Santé Article L161-37; 2008.
42. Hemminki, E, Hailey, D, Koivusalo, M. Health care policy - The courts - A challenge to health technology assessment. Science. 1999;285:203–204.
43. Henshall, C, Koch, P, von Below, GC, et al. Health technology assessment in policy and practice - Working group 6 report. Int J Technol Assess Health Care. 2002;18:447–455.
44. Henshall, C, Oortwijn, W, Stevens, A, Granados, A, Banta, D. Priority setting for health technology assessment. Theoretical considerations and practical approaches. Priority setting Subgroup of the EUR-ASSESS Project. Int J Technol Assess Health Care. 1997;13:144–185.
45. Hivon, M, Lehoux, P, Denis, JL, Tailliez, S. Use of health technology assessment in decision making: Coresponsibility of users and producers? Int J Technol Assess Health Care. 2005;21:268–275.
46. Hjelmgren, J, Berggren, F, Andersson, F. Health economic guidelines–similarities, differences and some implications. [see comment]. Value Health. 2001;4:225–250.
47. Hutton, J, McGrath, C, Frybourg, JM, et al. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). Int J Technol Assess Health Care, 2006;22:10–18.
48. Introduction to the EUR-ASSESS Report. Int J Technol Assess Health Care. 1997;13:133–143.
49. Jann, W, Wegrich, K. Phasenmodelle und Politikprozesse: Der Policy Cycle. In: Schubert, K, Bandelow, N, eds. Lehrbuch der Politikfeldanalyse. München/Wien; 2003.
50. Jonsson, E, Banta, D, Henshall, C, Sampietro-Colom, L. The ECHTA/ECAHI project. European Commission; 1999:1–552.
51. Kristensen, FB. First plenary session. Health technology assessment (HTA) in Europe - is harmonization possible? (Oral presentation). 11th Annual Congress of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). Athens, Greece, November 8–11, 2008.
52. Kuhn, T. The structure of scientific revolutions. Chicago: University of Chicago Press; 1962.
53. Lafortune, L, Farand, L, Mondou, I, Sicotte, C, Battista, R. Assessing the performance of health technology assessment organizations: A framework. Int J Technol Assess Health Care. 2008;24:76–86.
54. Lehoux, P, Tailliez, S, Denis, JL, Hivon, M. Redefining health technology assessment in Canada: Diversification of products and contextualization of findings. Int J Technol Assess Health Care. 2004;20:325–336.
55. Lehoux, P, Williams-Jones, B. Mapping the integration of social and ethical issues in health technology assessment. Int J Technol Assess Health Care. 2007;23:9–16.
56. Liberati, A, Sheldon, TA, Banta, HD. EUR-ASSESS project subgroup report on methodology. Methodological guidance for the conduct of health technology assessment. Int J Technol Assess Health Care. 1997;13:186–219.
57. Martelli, F, Torre, GL, Ghionno, ED, et al. Health technology assessment agencies: An international overview of organizational aspects. Int J Technol Assess Health Care. 2007;23:414–424.
58. McGivney, WT. Coverage, technology assessment, and the courts. Physician Exec. 1991;17:36–38.
59. Miles, MB, Huberman, AM. Qualitative data analysis. CA: Thousand Oaks: Sage; 1994.
60. Mintzberg, H. Die Mintzberg-Struktur. Organisationen effektiver gestalten. Landsberg/Lech: Verlag Moderne Industrie; 1992.
61. National Institute for Health and Clinical Excellence (NICE). Homepage on the Internet. http://www.nice.org.uk/ (accessed May 2008). 62. National Institute for Health and Clinical Excellence (NICE). Homepage on the Internet. Guide to the methods of technology appraisal [issued June 2008]. London, UK: http://www.nice.org.uk (accessed October 19, 2008).
63. Newcomer, LN. Technology assessment, benefit coverage, and the courts. In: Gelijns, AC, Dawkins, HV, eds. Adopting new medical technology, vol. 4. Washington, DC: National Academy Press; 1994:117–124.
64. Oliver, A, Mossialos, E, Robinson, R. Health technology assessment and its influence on health-care priority setting. Int J Technol Assess Health Care. 2004;20:1–10.
65. Oortwijn, W, Banta, HD, Cranovsky, R. Introduction: Mass screening, health technology assessment, and health policy in some European countries. Int J Technol Assess Health Care. 2001;17:269–274.
66. Organisation for Economic Co-operation and Development. The OECD Health Project. Health technology and decision making. Paris: OECD; 2005.
67. Perleth, M, Busse, R, Gerhardus, A, Gibis, BR, Luhmann, D, (Hrsg.). Health technology assessment. Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. Berliner Schriftenreihe Gesundheitswissenschaften. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2008:1–260
68. Perleth, M, Jakubowski, E, Busse, R. [“Best practice” in health care–or why we need evidence-based medicine, guidelines and health technology assessment]. Z Arztl Fortbild Qualitatssich. 2000;94:741–744.
69. Perleth, M, Jakubowski, E, Busse, R. What is ‘best practice’ in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. Health Policy. 2001;56:235–250.
70. Perry, S, Gardner, E, Thamer, M. The status of health technology assessment worldwide. Results of an international survey. Int J Technol Assess Health Care. 1997;13:81–98.
71. Perry, S, Thamer, M. Health technology assessment: Decentralized and fragmented in the US compared to other countries (corrected). Health Policy. 1997;42:269–290.
72. Perry, S, Thamer, M. Evaluation of health care technologies in the united states compared to Canada and European countries. J Public Health Policy. 1999;20:168–191.
73. Petherick, ES, Villanueva, EV, Dumville, J, Bryan, EJ, Dharmage, S. An evaluation of methods used in health technology assessments produced for the Medical Services Advisory Committee. Med J Aust. 2007;187:289–292.
74. Philips, Z, Bojke, L, Sculpher, M, Claxton, K, Golder, S. Good practice guidelines for decision-analytic modelling in health technology assessment: A review and consolidation of quality assessment. Pharmacoeconomics. 2006;24:355–371.
76. Sassi, F. The European way to health technology assessment. Lessons from an evaluation of EUR-ASSESS. Int J Technol Assess Health Care. 2000;16:282–290.
77. Velasco-Garrido, M, Perleth, M, Drummond, M, et al. Best practice in undertaking and reporting health technology assessments. Working group 4 report. Int J Technol Assess Health Care. 2002;18:361–422.
78. von Rosenstiel, L, Molt, W, Rüttinger, B. Organisationspsychologie. Stuttgart: W. Kohlhammer; 2005.
79. Wanke, M, Juzwishin, D, Thornley, R, Chan, L. An exploratory review of evaluations of health technologies assessment agencies. Alberta, Canada: Alberta Heritage Foundation of Medical Research (AHFMR); 2006:1–61.
81. Weiss, CH. The many meanings of research utilization. Public Adm Rev. 1976;39:426–431.
82. Werko, L, Banta, D. Report from the EUR-ASSESS Project. Int J Technol Assess Health Care. 1995;11:797–799.
83. Wild, C, Gibis, B. Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria. Health Policy. 2003;63:187–196.
85. Zentner, A, Velasco-Garrido, M, Busse, R. Methoden zur vergleichenden Bewertung pharmazeutischer Produkte. Eine internationale Bestandsaufnahme zur Arzneimittelevaluation. Köln: Deutsches Institut für Medizinische Dokumentation und Information (DIMDI); 2005:1–158.